MUSIC AND CHRONIC PAIN: A CLINICAL TRIAL

慢性非恶性疼痛(CNMP)影响着数以百万计的人，并导致无力、抑郁和残疾。药物干预有令人不快的副作用，只能起到部分缓解作用。这项实验研究的目的是检验和比较两种音乐干预对CNMP患者的力量、疼痛、功能障碍和抑郁的影响。90名背部、颈部和/或关节疼痛超过6个月的成年人将被随机分配到三组中的一组。模式治疗音乐(PMH)小组将使用自我选择的音乐和基于舒适度和情绪自我评估的音乐聆听技术。标准音乐(SM)组将使用研究人员提供的放松器乐，而对照组将不会收到任何音乐。据推测，在两个音乐组中，感觉到的疼痛、抑郁和功能障碍都会减少，而PHM组的减少更多，而且这种影响将通过权力来调节。麦吉尔疼痛问卷简表、疼痛残疾指数、流行病学研究中心抑郁量表和知晓参与改变的力量工具将用于检查音乐干预的效果。一小时的音乐干预将每天自我实施一次，连续七天，数据将在基线、第7天和第21天被记录下来。协方差分析将用于检验假设。如果提供音乐干预可以减少疼痛、抑郁和与CNMP相关的功能障碍，这将改善目前治疗选择有限的大量人口的生活质量。

Chronic non-malignant pain (CNMP) affects millions of individuals and results in powerlesssness, depression, and disability. Pharmacological interventions have unpleasant side effects and provide only partial relief. The purpose of this experimental study is to examine and compare the effects of two music interventions on power, pain, functional disability, and depression in individuals with CNMP. Ninety adults who have experienced back, neck, and/or joint pain for more than six months will be randomly assigned to one of three groups. The pattern-healing music (PMH) group will use self-selected music and music-listening techniques based on self-evaluation of comfort and mood. The standard music (SM) group will use relaxing instrumental music provided by the researcher, and the control group will receive no music. It is posited that perceived pain, depression, and functional disability will decrease in both music groups, that it will decrease more in the PHM group, and that this effect will be mediated by power. The McGill Pain Questionnaire Short-form, the Pain Disability Index, the Center for Epidemiological Studies Depression Scale, and the Power as Knowing Participation in Change Tool will used to examine the effect of the music interventions. One-hour music interventions will be self-administered once a day, for seven consecutive days and data will be recorded at baseline, day 7, and day 21. Analysis of covariance will be used to test the hypotheses. If providing a music intervention decreases pain, depression, and the functional disability associated with CNMP this will result in improved quality of life for a large population who currently have limited treatment choices.